Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 3
2008 1
2009 1
2013 1
2014 1
2016 1
2017 1
2018 2
2020 1
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Profiling CD antigens on leukaemias with an antibody microarray.
Barber N, Gez S, Belov L, Mulligan SP, Woolfson A, Christopherson RI. Barber N, et al. Among authors: woolfson a. FEBS Lett. 2009 Jun 5;583(11):1785-91. doi: 10.1016/j.febslet.2009.03.018. Epub 2009 Mar 17. FEBS Lett. 2009. PMID: 19298816 Free article. Review.
The messy biological basis of culture.
Woolfson A. Woolfson A. Nature. 2018 Feb;554(7690):30. doi: 10.1038/d41586-018-01326-5. Nature. 2018. PMID: 32094854 No abstract available.
Structural Capacitance in Protein Evolution and Human Diseases.
Li C, Clark LVT, Zhang R, Porebski BT, McCoey JM, Borg NA, Webb GI, Kass I, Buckle M, Song J, Woolfson A, Buckle AM. Li C, et al. Among authors: woolfson a. J Mol Biol. 2018 Sep 14;430(18 Pt B):3200-3217. doi: 10.1016/j.jmb.2018.06.051. Epub 2018 Jul 3. J Mol Biol. 2018. PMID: 30111491
Classification of AML using a monoclonal antibody microarray.
Christopherson RI, Stoner K, Barber N, Belov L, Woolfson A, Scott M, Bendall L, Mulligan SP. Christopherson RI, et al. Among authors: woolfson a. Methods Mol Med. 2006;125:241-51. doi: 10.1385/1-59745-017-0:241. Methods Mol Med. 2006. PMID: 16502589
First-in-Human Study of Utomilumab, a 4-1BB/CD137 Agonist, in Combination with Rituximab in Patients with Follicular and Other CD20+ Non-Hodgkin Lymphomas.
Gopal AK, Levy R, Houot R, Patel SP, Popplewell L, Jacobson C, Mu XJ, Deng S, Ching KA, Chen Y, Davis CB, Huang B, Fly KD, Thall A, Woolfson A, Bartlett NL. Gopal AK, et al. Among authors: woolfson a. Clin Cancer Res. 2020 Jun 1;26(11):2524-2534. doi: 10.1158/1078-0432.CCR-19-2973. Epub 2020 Mar 6. Clin Cancer Res. 2020. PMID: 32144134 Clinical Trial.
17 results